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Background: Due to the unparalleled genetic diversity of its peoples, Africa is attracting growing research
attention. Several African populations have been assessed in global initiatives such as the International HapMap
and 1000 Genomes Projects. Notably excluded, however, is the southern Africa region, which is inhabited
predominantly by southeastern Bantu-speakers, currently suffering under the dual burden of infectious and
non-communicable diseases. Limited reference data for these individuals hampers medical research and prevents
thorough understanding of the underlying population substructure. Here, we present the most detailed exploration,
to date, of genetic diversity in 94 unrelated southeastern Bantu-speaking South Africans, resident in urban Soweto
(Johannesburg).
Results: Participants were typed for ~4.3 million SNPs using the Illumina Omni5 beadchip. PCA and ADMIXTURE
plots were used to compare the observed variation with that seen in selected populations worldwide. Results
indicated that Sowetans, and other southeastern Bantu-speakers, are a clearly distinct group from other African
populations previously investigated, reflecting a unique genetic history with small, but significant contributions
from diverse sources. To assess the suitability of our sample as representative of Sowetans, we compared our results
to participants in a larger rheumatoid arthritis case–control study. The control group showed good clustering with
our sample, but among the cases were individuals who demonstrated notable admixture.
Conclusions: Sowetan population structure appears unique compared to other black Africans, and may have
clinical implications. Our data represent a suitable reference set for southeastern Bantu-speakers, on par with a
HapMap type reference population, and constitute a prelude to the Southern African Human Genome Programme.
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The African continent continues to attract a growing pro-
portion of research attention due to the unprecedented
level of genetic diversity of its peoples [1,2]. In particular,
northern and central African countries have been increas-
ingly incorporated into studies assessing human population
structure. The Luhya of Kenya, the Maasai of Kinyawa and
the Yoruba of Nigeria are well documented in both the
HapMap and 1000 Genomes Projects (http://hapmap.ncbi.
nlm.nih.gov; www.1000genomes.org); the latter of which* Correspondence: michele.ramsay@nhls.ac.za
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reproduction in any medium, provided the orwill also include data pertaining to Gambian (The
Gambia), Mende (Sierra Leone) and Esan (Nigeria) popu-
lations. The Human Genetic Diversity Project (HGDP)
provides genotyping information for populations residing
in the Central African Republic, the Democratic Republic
of Congo and Senegal [3], whilst independent assessments
of Malawian and Ethiopian genetic structure are also
available [4,5].
Less well represented in current research, however, are
inhabitants of the southern Africa region. Defined here as
the collection of Botswana, Lesotho, Swaziland, Namibia
and South Africa (according to the United Nations
Geoscheme, [6]), southern Africa is home to a predomin-
ant population of Bantu-speakers; a sub-group of the
Niger-Kordofanian (NK) linguistic group that expanded
southwards from Nigeria and Cameroon, beginning. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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South Africa ~1500 to 1000 years ago [9]. Specifically,
speakers belong to the “S” group of Bantu language classi-
fication [10,11], consisting of mostly Sotho-Tswana, Venda
and Nguni languages [12]. The genetic architecture of
NK-speakers, in general, has been described as fairly
homogeneous [2,13], despite their broad distribution
across the continent, however, few studies have sampled
extensively from southern African countries. The HGDP
includes only a scattering of southern Bantu-speakers
from South Africa (eight in total), whilst Tishkoff et al. [2],
Xing et al. [14], Schlebusch et al. [15] and Pickrell et al.
[16] include limited samples of 41, 27, 20 and 24 such in-
dividuals respectively. These individuals were interrogated
using a comparatively small selection of genetic markers
(with the exception of Schlebusch and colleagues who
typed ~2.5 million single nucleotide polymorphisms
[SNPs]), restricting the information density. The resulting
data are thus not ideal as a suitable reference resource that
captures the genetic diversity of the region’s dominant
ethnolinguistic group.
The lack of local genetic information with robust allele
frequency distributions currently serves as a significant hur-
dle to designing biomedical research and may have import-
ant medical implications. With the highest worldwide
prevalence of HIV/AIDS [17] and rising rates of diseases of
lifestyle due to rapid urbanisation, southern Africa suffers
under the full weight of medical needs, including commu-
nicable, non-communicable, perinatal and maternal disor-
ders [18]. According to the World Health Organisation
[19], roughly 60% of deaths within southern African coun-
tries are attributable to communicable diseases, whilst 30%
are caused by non-communicable disorders. Hitherto, in-
vestigations into the population-specific genetic causes
underpinning these diseases have largely relied on the
HapMap reference data for Yoruba and Luhya populations
to guide study design. However, the accuracy of this ap-
proach remains in doubt, as it is still unclear to what extent
tag SNPs from the Yoruba or Luhya can be ported to other
Africans [20,21]. Moreover, southern Africans are geo-
graphically distant from these proxy populations, resulting
in genetic differentiation due to genetic drift, different selec-
tion pressures and admixture with different indigenous
groups (such as Khoe and San groups) [22]. The generation
of local genetic information therefore presents several key
benefits in both evaluating the applicability of proxy popu-
lations within Africa as well as providing a more accurate
reference foundation on which to support future disease re-
search. In addition, it provides a reference from which to
identify local founder effects, signatures of selection, levels
of admixture and allele frequency variations. Such benefits
facilitate the future ideals of personalised medicine, and the
knowledge gleaned may well have uses for other popula-
tions worldwide, given Africa’s importance for humanhistory. It is these reasons that provided the impetus for the
Southern African Human Genome Programme (SAHGP)
[23], which ultimately aims to provide a comprehensive,
publically available database of genetic information for this
region.
As a prelude to the SAHGP, we sought to investigate
the genetic diversity amongst urban black South Africans
residing in the Soweto-Johannesburg metropolitan area
of the Gauteng province - one of the urban centres in
South Africa most densely populated by southeastern
Bantu-speakers. Soweto is a major contributor to South
Africa’s leading rates of urbanization [24], retaining a
regular influx of migrant workers (and refugees) since the
gold-mining era [25,26], who intermix with local inhabi-
tants. This sets the stage for substantial genetic mixing
between separately defined ethnolinguistic subgroups,
further complicated by known Caucasian and Indian in-
fluences on the area. Accompanying rapid urbanization is
a simultaneous transition in epidemiology. For example,
the Heart of Soweto study [27] has uncovered distressing
statistics that point to a widening spectrum of both trad-
itional forms of infectious heart disease as well as non-
communicable forms more commonly seen in developed
countries. As a pertinent demonstration, the atheroscler-
otic disease phenotype that was once largely unobserved
amongst black South Africans, was documented in 14%
of study cases. Indeed, more than 75% of black South
Africans are now considered to possess at least one major
risk factor for heart disease [28]. More generally, Mayosi
and colleagues [18] reviewed the overall burden of non-
communicable disease in South Africa, citing numerous
references that demonstrate the increasing prevalence of
these diseases. Specifically, they noted the unequal distri-
bution of disease, with the heaviest burden being endured
by poor communities in an urban context, as is typical of
Soweto. Thus, we aimed to provide a closer examination
of genetic variation within Soweto, with the main pur-
pose of providing a more accurate reference dataset for
medical and genetic research. We contrasted this vari-
ation with selected populations worldwide, with the view
of placing southeastern Bantu-speakers in the context of
global genetic diversity. Finally, to assess the applicability
of such a reference, we sought to determine how similar
a larger random sample of black Sowetans was to our
own “reference set” by incorporating results from a re-
cent case–control study on rheumatoid arthritis in
Soweto, and used the comparison to note certain impli-
cations for genomic research in southern Africa.
Results
Performance
It is commonly accepted that the inadequacy of SNP
chips is exposed when used to assess most African popu-
lations [29]. Thus, to compare the performance of our
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other populations, we obtained allele frequency data for
the CEU (Utah residents with ancestry from northern
and western Europe), YRI (Yoruba in Ibadan, Nigeria),
CHB (Han Chinese in Beijing, China) and JPT (Japanese
in Tokyo, Japan) HapMap samples that were genotyped
on the Omni5 chip, in-house, by Illumina. For each
population, the distribution of minor allele frequencies
was plotted. Note that minor allele designation was
dependent on genotyping frequencies per population,
thus the minor allele per SNP may be different between
populations. Results are shown in Figure 1. Our samples
performed similarly to those of the YRI, with a slighter
higher fraction of markers with an allele frequency less
than 2.5%, but a lower fraction of markers with a minor
allele frequency between 2.5 and 10%, as well as a lower
percentage of monomorphic SNPs. A clear bias for low
frequency variants was noted for CEU individuals, as
SNP selection for the Omni5 was largely based on
European data. Asian populations (CHB and JPT) fared
least well, with over 50% of markers typed as mono-
morphic and, therefore, of reduced utility.
Principal components analysis (PCA)
To contextualise Sowetan genetic variation, PCA plots
(based on 460 568 SNPs) were generated from theFigure 1 Minor allele frequency comparison for different populations
allele frequencies for black Sowetan (BSO; n = 94) individuals to those generate
that minor allele designation was dependent on genotyping frequencies per p
populations. BSO individuals had an increased fraction of SNPs with minor allel
monomorphic SNPs (0 MAF), when compared to their African counterparts, th
marginally larger fraction of SNPs, but levels remained comparable between th
and 50%. Performance was best for CEU (n = 113), with a low percentage of m
markers. Conversely, Asian [CHB (n = 44) and JPT (n = 40)] populations fared pcombined dataset (Figures 2 and 3) where data from dif-
ferent population combinations, as well as different prin-
cipal components are shown. Figures 2a) and 2b)
demonstrate intercontinental variation, and include the
major African, Asian and European representatives. We
included Gujarati Indians in Houston, Texas (GIH) as
well, based on historical accounts of Indian influences on
the Sowetan gene pool. With respect to principal compo-
nents (PC) 1 and 2, populations were positioned into
broad continental clusters, with the exception of the GIH
who clustered separately. BSO individuals clustered along
with other black African populations (YRI, LWK and
SEB) speaking a Niger-Kordofanian language, whilst the
Nilo-Saharan speaking Maasai appear as a distinct clus-
ter. Selected BSO individuals appeared to position
spatially in the direction of CEU and GIH populations,
reflecting possible admixture.
Principal components 3 and 4 more clearly distin-
guished African populations from one another. Compo-
nent 3 highlights the separation between Europeans,
Oriental populations and Gujarati Indians, the latter of
which appears as an extended cluster. Component 4 dis-
aggregates African populations along a north–south gradi-
ent, with a correspondingly clear distinction between
Sowetans and the more northern African groups. South-
eastern Bantu-speakers (SEB) typed by Schlebusch et al.typed on the Omni5 chip. We compared the distribution of minor
d in-house, by Illumina, for the CEU, CHB, JPT and YRI populations. Note
opulation, thus the minor allele per SNP may be different between
e frequencies between 0 and 2.5%, as well as a lower proportion of
e Yoruba (n = 55). Between frequencies of 2.5 and 10%, the YRI had a
e two African groups for common variants with frequencies between 10
onomorphic SNPs and a significantly greater proportion of rare (1-5%)
oorly, with over half of all markers on the Omni5 panel lacking variation.
ab
Figure 2 Intercontinental PCA plots comparing Sowetan genetic variation to populations worldwide. Sowetan genetic variation was
compared to that seen worldwide using principal component analysis. Our data were combined with Omni2.5 data generated as part of the 1000
Genomes Project. We incorporated the main representatives for the European (CEU), Asian (CHB and JPT) and African (LWK, MKK and YRI)
continents, as well as Gujarati Indians (GIH) based on reported Indian contributions to the Sowetan gene pool. a) Principal components (PC) 1 and
2 divide populations into broad continental clusters, with the exception of GIH. The BSO overlap well with other Africans of the Niger-Kordofanian
linguistic group. Nilo-Saharan speaking Maasai are positioned nearby, reflecting the separate history of this linguistic branch. Several BSO
individuals separate out from the cluster, indicating possible admixture. b) PC3 separates Asian, European and Indian populations, whilst PC4
disaggregates Africans along a north–south gradient. BSO and SEB are clearly distinguished from other black Africans and are more loosely
clustered. Plots are based on a panel of 460 568 markers. Refer to Table 1 for sample sizes per population.



























Figure 3 Intracontinental PCA plot comparing Sowetan genetic variation to other black Africans. To examine African genetic variation in
more detail, a PCA plot was generated that incorporated only BSO, SEB, YRI, MKK, LWK, KAR, KHO and NAM populations. PC1 separated populations
along a north–south split, whilst the Nilo-Saharan speaking Maasai separated out along PC2. Khoe-San groups (KAR, KHO and NAM) displayed
limited clustering in line with previous reports on their unparalleled genetic diversity. Noticeably, BSO clustering was weaker than that seen in
northern Africans, suggesting a greater degree of interindividual variation. Plot was based on a panel of 460 568 markers. Refer to Table 1 for
sample sizes per population. BSO - Southeastern Bantu-speakers from the Soweto region; KAR - Karretjie in South Africa; KHO - Khomani in South
Africa; LWK - Luhya in Webuye, Kenya; MKK - Maasai in Kinyawa, Kenya; NAM - Nama in Namibia; SEB - Southeastern Bantu-speakers; YRI - Yoruba in
Ibadan, Nigeria.
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Soweto demographics. In both plots, clustering amongst
BSO individuals appeared to be more dispersed compared
to other African groups, with a greater overall spread.
To investigate the distinctions between African popu-
lations further, we generated an intracontinental plot
that included only African populations, namely the BSO,
SEB, YRI, MKK, LWK, KAR (Karretjie), KHO (Khomani)
and NAM (Nama) (Figure 3). In agreement with typical
plots of PC1 versus PC2, black African populations dem-
onstrated a clear separation as a consequence of their
geographic distance from each other [14], with PC1
reflecting a north–south split. The Maasai are separated
out along PC2, whilst the Khoe-San groups showed lim-
ited clustering in accordance with their high genetic di-
versity [15]. Again, BSO clustering was noticeably
weaker than that seen for northern Africans, suggesting
a greater degree of interindividual variation.
Admixture
ADMIXTURE results for ancestral populations K=2 to
K=5 and K=2 to K=6, for intracontinental and intercon-
tinental datasets respectively, are shown in Figure 4.
Intracontinentally (Figure 4a), the present study sample
was seen to closely resemble SEB, in confirmation ofobserved PCA results. From K=2, YRI individuals were
already distinguished from their African counterparts. By
K=3, clear separation between BSO, YRI, MKK and LWK
populations was evident, along with a clear link between
southeastern Bantu-speakers and the southern Khoe-San,
in confirmation of previous reports [15,30]. At K=5, BSO
and SEB presented with greater diversity in admixture
than northern Africans. Intercontinentally (Figure 4b),
K=2 separated Africans from non-Africans, whilst K=3
and K=4 formed African, European and Asian clusters,
with GIH initially shown as having mixed ancestry from
both Europe and Asia (K=3) before separating as a dis-
tinct population at K=4. With increasing K clusters,
African populations are increasingly distinguished. In
particular, Bantu-speakers appeared to be significantly
different with relatively small contributions from all 6 an-
cestral populations; a result that was not typical for mem-
bers of the other populations investigated.
Sample comparison
To examine how well our reference Soweto sample
represented another larger and independently selected
sample of unrelated black Sowetans, we performed a
comparison with data from a case–control study for
rheumatoid arthritis. PCA results are displayed in
a b Figure 4 ADMIXTURE plots comparing genetic variation in
Sowetans to that seen worldwide. ADMIXTURE was used to
compare genetic composition of Sowetans to other populations
worldwide, based on 460 568 SNP markers. a) When incorporating
African populations only, the Yoruba (YRI) are distinguished from
other Africans from K=2. At K=3, southeastern Bantu-speakers (BSO
and SEB) are discerned from the Luhya (LWK) and Maasai (MKK), but
share a degree of ancestry with Khoe-San groups (KAR, KHO, NAM).
Both K=4 and K=5 increasingly depict each African population as a
unique entity, in line with the diverse genetic architecture of the
continent. b) At an intercontinental level, K=2 separates Africans
from non-Africans whilst K=3 groups populations broadly into Asian
(CHB, JPT), European (CEU) and African categories. K=4 then
differentiates Gujarati Indians (GIH) beyond a simple mix of
European and Asian genetic variation. Increasing K values separate
out African populations along the lines described in a). At K=6, BSO
and SEB appear highly diverse, possessing contributions from all six
ancestral clusters.
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of the African continent to just CEU and GIH due to
reported admixture with BSO. Comparative data were
available for 21 412 SNPs. Controls (SCO) from the study
closely matched the clustering pattern of the BSO group,
suggesting similar overall genetic profiles. Interestingly,
the cases (SCA) demonstrated a wider spread of vari-
ation, strongly indicative of varied degrees of admixture
with Europeans and Indians.
Discussion
The rapid urbanisation of Soweto and its subsequent
epidemiological transition are largely representative of
the transformations occurring across the developing
southern Africa region [27,31-33]. Consequently, the
area’s predominant ethnic group of southeastern Bantu-
speakers constitute one of the African continent’s largest
health burdens, and understanding their susceptibility to
disease, both communicable and non-communicable,
grows increasingly important. Progress, however, is ham-
pered by a paucity of genetic data that necessitates the
use of proxy populations; an approach with obvious limi-
tations. An appropriate reference dataset would thus
greatly improve local research capabilities and obviate
the need for proxy genetic data. In the present study, we
sought to address the lack of reference data and contrast
Sowetan genetic variation to that seen worldwide, and
more specifically, within Africa.
Using principal component analysis, we noted two im-
portant observations. Firstly, we confirmed that south-
eastern Bantu-speakers (BSO and SEB) occupy a distinct
space from northern Africans. Secondly, we observed a
relatively loose clustering of BSO individuals, consistent
with the demographic “melting pot” of the urban Soweto
community. In confirmation, ADMIXTURE results sug-
gested Sowetans comprise of small contributions from a

























Figure 5 Principal component analysis of Sowetan cases and controls recruited for a rheumatoid arthritis association study. To assess
the validity of our own sample as a suitable reference for the black Sowetan population, we used PCA to compare results with independently recruited
case (SCA; n = 304) and control (SCO; n = 318) samples selected for a rheumatoid arthritis study. Cases and controls matched the clustering pattern of BSO
individuals, supporting the use of the latter as a reference sample. However, a minority of cases displayed wider dispersal, with several individuals
positioned more closely to Indian and European populations. Plot was based on a panel of 21 412 SNPs. BSO - Southeastern Bantu-speakers from the
Soweto region; CEU - Utah residents of European ancestry; GIH - Gujarati Indians from Houston, Texas; LWK - Luhya in Webuye, Kenya; MKK - Maasai in
Kinyawa, Kenya; SCA - Black Sowetan case individuals with rheumatoid arthritis; SCO - Black Sowetan control individuals; SEB - Southeastern Bantu-speakers;
YRI - Yoruba in Ibadan, Nigeria.
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gated, with the exception of the Khoe-San. Such varied
contributions, however, were not significant enough to
detract from the general homogeneity of the group
(consisting of DNA from primarily one ancestral popula-
tion), suggesting that most migration and admixture into
Soweto is likely from areas where individuals have a
similar genetic heritage. Consequently, the average level
of admixture is unlikely to significantly interfere with
the analysis of disease association studies. However, indi-
viduals with significant admixture also form part of the
Sowetan population [as witnessed in Figure 5]. It is
therefore necessary to screen for such individuals and
to exclude them from phenotype-genotype association
studies, in order to avoid false positive associations as
a result of underlying population structure.
Amongst the numerous and diverse sources of genetic
variation, Bantu-speakers are specifically known to dis-
play levels of Khoe-San admixture [2,34,35]. Our results
confirm a degree of admixture between the BSO and the
more southerly located Khoe-San (Figure 4a), including
the Nama, the Khomani and the Karretjie peoples (whose
unsurpassed genetic variation is explored in greater detail
elsewhere [15,16]). This admixture likely underpins the
weaker clustering of southeastern Bantu-speakers, and
uniquely distinguishes them from northern Africans.Indeed, the separation observed between NK-speaking
populations included in the present study highlights
some of the key benefits to improved marker density and
more focused comparisons between populations when
assessing genetic structure. Although fairly homogenous
when considered on a global scale [2], our comparisons
at the intracontinental level revealed significant hetero-
geneity between western (YRI), central (LWK) and south-
ern (BSO) NK-speakers. Both PCA and ADMIXTURE
analyses suggest BSO are dissimilar from the populations
commonly used as their proxy (YRI and LWK), with
greater interindividual genetic variation. These findings
support the use of more detailed assessments of popula-
tion genetic structure to improve the resolution between
closely related, but nonetheless distinct groups of individ-
uals. Moreover, they augment the value of local genetic
information, especially when researching the more in-
nately diverse African populations.
In confirmation that our sample was a good representa-
tion of the larger Soweto population, we investigated its
similarity to a sample of over 600 individuals from a re-
cent rheumatoid arthritis case–control study (Govind
et al. in preparation). The cases and controls were separ-
ately identified and in the comparisons, the controls clus-
tered tightly with the BSO group, reflecting their common
origin, and thus strengthening the applicability of our data
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[according to Statistics South Africa [36], the 2011 Census
demonstrated that Gauteng closely mirrors the relative
distribution of speakers of the nine Bantu-languages in
South Africa as a whole]. Interestingly, among the cases,
the majority clustered closely with the BSO, but a minor-
ity displayed significant admixture, with a wider spread of
genetic variation, despite being selected on the grounds of
self-reported black ethnicity. To what reason this wider
dispersal is owed remains unclear. Most likely, the more
admixed individuals within the group are not permanent
residents of the Soweto region, but may have been re-
ferred from other locations in order to receive specialised
medical treatment beyond the scope of local clinics. Con-
trols were all workers at the hospital (cleaners, nurses,
clerks etc.), and thus more inclined to reside permanently
in Soweto. The more divergently clustering individuals
with significant Indian and Caucasian admixture were re-
moved from the rheumatoid arthritis association study be-
fore analysis (Govind et al. in preparation), according to
quality control procedures. However, information on di-
vergent and significant admixture in specific individuals is
not typically available to health care professionals, and
may have important health-related implications since self-
reported ethnicity may be used to guide medical advice,
including the prescription of drugs. Numerous studies
have already reported on certain locus specific population
effects concerning drug metabolism, particularly for drugs
used to treat cancer and HIV [37-40]. This comparison
thus emphasises the value of obtaining local genetic infor-
mation to highlight ethnic nuances of potentially import-
ant clinical relevance.
The performance of the Omni5 in assessing African
genetic variation merits comment. Based on our compar-
isons, the platform performs well in typing common vari-
ation in Africans, and will have use in genome-wide
association studies. Beneficially, the superior marker
density improves the chances for positive associations,
which are more likely to progress to the identification of
causal variants due to the limited linkage disequilibrium
(LD) of African populations [20]. Conversely, limited LD
may result in poor detection of association, compounded
by the lack of private African alleles on the platform. Re-
gardless, true progress in meeting the medical demands
of southeastern Bantu-speakers, and indeed all Africans,
will be subordinate to an increased collection of complete
genome sequences, which will further outline unique
African variation and facilitate the improved stratification
of individuals by genetic composition. For example,
targeted resequencing of the CYP3A4 gene in a sample
comprised of Khoe-San, Xhosa and Mixed Ancestry indi-
viduals from South Africa identified 24 SNPs, two of
which were novel, non-synonymous variants [41]. Only
one third (8/24) of these variants are included on theOmni5 chip, whilst the novel variation is likely to be pri-
vate to the African continent, suggesting that full genome
sequencing of black Africans will be a necessity if we are
to enhance our understanding of the genetic architecture
of these peoples. Beyond population stratification, a more
thorough appreciation of confounding environmental
factors will also need to be fostered [42], especially given
the spectrum of living conditions on the continent; from
arid to tropical and from rural to urban [1]. Despite these
concerns, as one of the most comprehensive genotyping
chips currently available, the Omni5 represents a good
option for those wishing to pursue GWAS in African
populations, based on the performance levels we have
witnessed here.
Several limitations to the present study are acknowl-
edged. Ideally, a larger sample size and complete genome
sequences would more accurately reflect the full spectrum
of genetic diversity across southeastern Bantu-speakers.
Our sample of 94 individuals does, however, compare in
size to those of the HapMap and 1000 Genomes Projects,
which have more than demonstrated their value as refer-
ence panels for specific populations. The comparison to
Sowetans in the rheumatoid arthritis study was done pri-
marily with markers related to loci relevant to auto-
immune disease, which may have introduced some bias,
since they may have been involved in significant selection
pressures as highlighted by Schlebusch et al. [15]. Lastly,
the Illumina Omni5 chip is subject to an ascertainment
bias for SNP selection, favouring those polymorphic in
European populations, and thus potentially distorting
some of the conclusions drawn [43]. In addition, the
Omni5 was designed to assess mostly common variants in
European populations with a frequency greater than 1%,
meaning that the characterisation and distribution of rare
variants is still to be incorporated in the assessment of
Sowetan genetic structure.
Our data have begun to address the paucity of southern
Africa genetic information, although considerable work re-
mains in sampling more broadly across the region. Numer-
ous other ethnicities, including the Cape Mixed Ancestry,
southwestern Bantu-speakers (Herero) and Afrikaner pop-
ulations inter alia, present interesting genetic diversity in
their own rights, distinct from that seen amongst the more
populous southeastern Bantu-speakers. Several studies
have already commenced with the documentation of this
variation [15,30,44], but it is the larger aim of the SAHGP
to provide more thorough reference databases on par with
those available for selected populations participating in the
International HapMap and 1000 Genomes Projects. Forth-
with, the data of the present study may, therefore, be con-
sidered the southeastern Bantu-speaker equivalent of a
HapMap reference for this population. Future studies will
aim to mine these data further, attempting to extract infor-
mation of particular biomedical relevance.
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To conclude, our investigative search into Sowetan genetic
variation is, to date, the most detailed of its kind. We have
observed a distinct genetic profile for these individuals,
different from other more widely studied African popula-
tions, supported by principal component analysis as well
as ADMIXTURE. Combined, these results aligned well
with demographic and historical knowledge on the inhabi-
tants of the Soweto region, clearly highlighting the signifi-
cant, but relatively small genetic contributions from far
and wide, that have been made to the local gene pool. We
have demonstrated that this dataset is a good reference
sample for future research on black South Africans who
speak southeastern Bantu languages. Most importantly,
some of the implications for future medical policy and re-
search are highlighted. Lastly, the dataset may be consid-
ered a first step toward the SAHGP, and is available at
http://sbimb.core.wits.ac.za/data/SNPgenotyping_01.html.Methods
Samples
Study participants included 94 unrelated southeastern
Bantu-speaking South African individuals (43 males and
51 females), residing in the Soweto-Johannesburg metro-
politan area whose ethnicity was captured from municipal
birth notification forms. These individuals are existing par-
ticipants in a longitudinal birth cohort and were all born
in 1990 [45]. Following informed consent, a 10ml sample
of venous blood was drawn, and DNA was extracted using
the salting-out procedure [46]. Extracted DNA was nor-
malized to 50ng/μl, in TE buffer. This study was approved
by the University of Witwatersrand, Human Research Ethics
Committee (Medical) – clearance number M110744.Table 1 Population data1 used for the present study
Source Population Description




CEU Utah residents of European ancestry
CHB Han Chinese in Beijing, China
JPT Japanese in Tokyo, Japan
GIH Gujarati Indians from Houston, Texas
YRI Yoruba in Ibadan, Nigeria
LWK Luhya in Webuye, Kenya
MKK Maasai in Kinyawa, Kenya
Schlebusch and
colleagues
KAR Karretjie in South Africa
KHO Khomani in South Africa
NAM Nama in Namibia
SEB Southeastern Bantu-speakers
1With the exception of the present study, all data were generated through the IllumGenotyping
Participants were genotyped using Infinium Omni5
beadchips (Illumina, San Diego, USA). DNA samples
were prepared in accordance with the Infinium LCG
assay (Part # 15025908, Revision A, June 2011 – available
from http://www.illumina.com/support/documentation.
ilmn). Beadchips were scanned on the Illumina iScan
(Illumina, San Diego, USA). Raw data were inspected
using Genomestudio (version 2011.1) and genotype calls
were made based on a clustering manifest supplied by
Illumina.Quality control
PLINK [47] was used to assess genotyping quality
according to the protocol published by Anderson and col-
leagues [48]. Samples were checked for discordant sex in-
formation (mismatches between documented sex and that
suggested by genotyping data), outlying heterozygosity
(more than 3 standard deviations from the mean), elevated
rates of missing data (genotyping failure rate > 3%), and
possible relatedness (identity by descent score > 0.185).
Individual SNPs (4 240 992 in total) were checked for
excess missingness (missing call-rate above 3%), and
markers with a minor allele frequency less than 1% (includ-
ing monomorphic SNPs) and/or a Hardy-Weinberg
equilibrium P-value less than 1 × 10-4 were removed.
Additionally, all X, Y and mitochondrial SNPs were
removed, along with those with unknown chromosome
location, leaving 2 417 298 markers prior to merging.Public datasets
For comparative purposes, we obtained publicly available
Omni2.5 chip data from the 1000 Genomes Projectn2 Reference
94












ina Omni 2.5 platform. 2Number of individuals in the test sample.
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http://www.biomedcentral.com/1471-2164/14/644(1kGP) (2012/01/31 release). We also obtained genotyping
data for southeastern Bantu-speakers and the southern
Khoe-San groups from Schlebusch and colleagues (2012)
(see Table 1). We limited our selection of Khoe-San groups
to those more southerly located as they appear to share
more admixture with southeastern Bantu-speakers. South-
western Bantu-speakers (Herero) were excluded due to a
limited sample size (8). These datasets were individually
assessed by the same quality control protocol listed above,
resulting in 1 500 508 and 1 773 030 high-quality markers
for the 1kGP and Schlebusch et al. datasets respectively.
These data were then merged to the present study data
using PLINK. SNPs that were mismatched for strand were
flipped where possible and A/T and C/G markers were re-
moved. After merging, markers with a genotyping success
rate lower than 95% were removed to ensure that only
overlapping markers between datasets were retained. The
final SNP panel consisted of 460 568 markers.
A subset of our results was also compared to those from
a recent study on rheumatoid arthritis (Govind et al. in
preparation). Briefly, 304 affected individuals and 318
healthy controls (all sourced from a Sowetan-based hos-
pital) were typed on the Illumina Infinium Immunochip
(Illumina, San Diego, USA) [49], consisting of ~196 000
genetic variants known to pertain to autoimmune disorder
susceptibility. As before, genotyping success thresholds
were imposed in order to retain only overlapping markers
between the Omni5 and Immunochips, resulting in a final
panel of 21 412 SNP markers.
Data analysis
PLINK was used to generate the necessary minor allele
frequency statistics that allowed the assessment of the per-
formance of BSO samples on the Omni5 chip. To com-
pare variation between populations, the smartpca.perl
script, part of the EIGENSTRAT suite (version 3.0; Helix
Systems, Maryland, USA), was used to calculate Eigen
vectors that determined the relative principal components.
These components were then plotted using Gnuplot
(version 4.6) [50]. ADMIXTURE (version 1.22) [51],
CLUMPP (version 1.1.2) [52] and Distruct (version 1.1)
[53] were used in combination to produce plots for K=2
to K=6 ancestral populations where applicable, calculated
from 100 permutations. To ensure no bias was introduced
into the PCA analysis due to variations in sample size, we
conducted 50 random samplings of 50 individuals from
each population studied (the Khoe-San were treated as a
single group). Inter- and intracontinental PCAs using
these subsamples demonstrated negligible variation in
general patterning and clustering when compared to PC
analysis of the full sample sizes (data not shown).
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